04 May 2007
Significant discrepancy between real-time PCR identification and hospital identification of C. albicans from Lebanese patients
Suha Yazbek, Ghyda Barada, Raida Basma, Jad Mahfouz, Roy A. KhalafMed Sci Monit 2007; 13(5): MT7-12 :: ID: 484614
Abstract
Background: The fungus C. albicans is among the leading agents causing death in immunocompromised patients. Most hospitals rely on conventional morphological techniques such as the germ-tube assay
and the API system for correct identifi cation. This technique is subjective and hence error prone. Recently, more and more molecular techniques for correct identifi cation have been developed. The latest is the LightCycler real-time PCR technique coupled with melting curve analysis.
Material/Methods: One hundred hospital isolates presumed to be C. albicans from four major Lebanese hospitals were tested using the real-time PCR technique. The results were compared with a germ-tube test.
Furthermore, all real-time PCR-positive samples were replica plated on growth media at 30°C and 45°C to differentiate between C. albicans and C. dubliniensis. Finally, all PCR-negative samples were identifi ed using the API 20C AUX yeast identifi cation system.
Results: Twenty-four hospital isolates were non-albicans by PCR (ppC. albicans-negative isolates were misidentifi ed by the API 20C AUX. None of the C. albicans real-time PCR-positive samples failed to grow at 45°C, the
dubliniensis non-permissive temperature.
Conclusions: Considering the impact of false identifi cation on the general public health through the use of wrong antifungal drug treatment and the emergence of novel drug-resistant strains, hospitals should update their classifi cation methods using molecular techniques.
Keywords: Candidiasis - drug therapy, Candida albicans - genetics, Antifungal Agents - therapeutic use, Drug Resistance, Fungal, Hospitals, Lebanon, Mycological Typing Techniques, Polymerase Chain Reaction - methods
Editorial
04 June 2022 : Editorial
Editorial: Acute Hepatitis of Unknown Origin in Children. Is Autoimmunity at Play?DOI: 10.12659/MSM.937371
Med Sci Monit 2022; 28:e937371
In Press
23 Jun 2022 : Clinical Research
A Real-World Study to Compare the Safety and Efficacy of Paritaprevir/Ombitasvir/Ritonavir and Dasabuvir, w...Med Sci Monit In Press; DOI: 10.12659/MSM.936706
22 Jun 2022 : Clinical Research
A Single-Center Study Comparing the Effects of Thoracic Spine Manipulation vs Mobility Exercises in 26 Offi...Med Sci Monit In Press; DOI: 10.12659/MSM.937316
21 Jun 2022 : Clinical Research
Optimal Timing and Outcomes of Minimally Invasive Approach in Acute Biliary PancreatitisMed Sci Monit In Press; DOI: 10.12659/MSM.937016
16 Jun 2022 : Clinical Research
Renal Manifestations in Inflammatory Bowel Disease: A Cohort Study During the Biologic EraMed Sci Monit In Press; DOI: 10.12659/MSM.936497
Most Viewed Current Articles
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Nov 2020 : Review article
Long-Term Respiratory and Neurological Sequelae of COVID-19DOI :10.12659/MSM.928996
Med Sci Monit 2020; 26:e928996
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952